Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

Sysmex Corporation (6869.T)

2,660.50
+10.50
+(0.40%)
At close: April 25 at 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
461,510,000
461,510,000
410,502,000
363,780,000
305,073,000
Cost of Revenue
219,013,000
219,013,000
194,419,000
173,195,000
150,770,000
Gross Profit
242,497,000
242,497,000
216,082,000
190,585,000
154,302,000
Operating Expense
161,902,000
161,902,000
140,033,000
123,167,000
104,291,000
Operating Income
80,595,000
80,595,000
76,049,000
67,418,000
50,011,000
Net Non Operating Interest Income Expense
-1,449,000
-1,449,000
-703,000
-359,000
-446,000
Pretax Income
74,600,000
74,600,000
68,713,000
64,346,000
46,251,000
Tax Provision
24,826,000
24,826,000
22,988,000
20,274,000
14,385,000
Net Income Common Stockholders
49,639,000
49,639,000
45,784,000
44,093,000
31,905,000
Diluted NI Available to Com Stockholders
49,639,000
49,639,000
45,784,000
44,093,000
31,905,000
Basic EPS
79.27
79.27
72.94
70.29
50.91
Diluted EPS
79.24
79.24
72.91
70.16
50.82
Basic Average Shares
626,201.59
626,201.59
627,681
627,273
626,715
Diluted Average Shares
626,438.67
626,438.67
627,960
628,422
627,759
Total Operating Income as Reported
78,382,000
78,382,000
73,679,000
67,416,000
50,010,000
Total Expenses
380,915,000
380,915,000
334,452,000
296,362,000
255,061,000
Net Income from Continuing & Discontinued Operation
49,639,000
49,639,000
45,784,000
44,092,000
31,904,000
Normalized Income
51,113,538.07
51,113,538.07
47,406,080
44,092,000
31,904,000
Interest Income
937,000
937,000
863,000
550,000
420,000
Interest Expense
2,386,000
2,386,000
1,566,000
909,000
866,000
Net Interest Income
-1,449,000
-1,449,000
-703,000
-359,000
-446,000
EBIT
76,986,000
76,986,000
70,279,000
65,255,000
47,117,000
EBITDA
112,874,000
112,874,000
102,086,000
92,686,000
72,533,000
Reconciled Cost of Revenue
219,013,000
219,013,000
194,419,000
173,195,000
150,770,000
Reconciled Depreciation
35,888,000
35,888,000
31,807,000
27,431,000
25,416,000
Net Income from Continuing Operation Net Minority Interest
49,639,000
49,639,000
45,784,000
44,092,000
31,904,000
Total Unusual Items Excluding Goodwill
-2,210,000
-2,210,000
-2,368,000
--
--
Total Unusual Items
-2,210,000
-2,210,000
-2,368,000
--
--
Normalized EBITDA
115,084,000
115,084,000
104,454,000
92,686,000
72,533,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-735,461.93
-735,461.93
-745,920
--
--
3/31/2021 - 1/1/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1EW.MI Edwards Lifesciences Corporation
66.62
+0.86%
 
BOUL.ST Boule Diagnostics AB (publ)
8.16
+1.96%
 
EKF.L EKF Diagnostics Holdings plc
21.00
+2.44%
 
COH.AX Cochlear Limited
264.62
-0.19%
 
BIO Bio-Rad Laboratories, Inc.
242.63
-2.85%
 
EW Edwards Lifesciences Corporation
76.04
+1.21%
 
SYK Stryker Corporation
365.06
+1.11%